Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden.

A Osterborg; A Ahre; M Björkholm; M Björeman; G Brenning; G Gahrton; G Grimfors; H Gyllenhammar; R Hast; B Johansson

doi:10.3109/02841869009092991

Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden.

Identifier:nobleid.org/w1/20260515/F66F56BA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F66F56BA.svg?ark=w1%2F20260515%2FF66F56BA)](https://nobleid.org/work/w1/20260515/F66F56BA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden.

Identifier:nobleid.org/w1/20260515/F66F56BA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F66F56BA.svg?ark=w1%2F20260515%2FF66F56BA)](https://nobleid.org/work/w1/20260515/F66F56BA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work